Rocilinostat is a specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity. HDAC inhibitors focus on HDAC enzymes, hindering the growth of cancer cells and triggering apoptosis, the programmed death of cancer cells. Reagent-grade; for laboratory research purposes only.
Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye